RA Capital Management’s Spyre Therapeutics SYRE Stock Holding History

RA Capital Management’s Portfolio SYRE Stock Details SYRE Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$53.1M	Buy
2022 Q4	–	Sell
2022 Q3	$5K	Buy
2016 Q4	–	Sell
2016 Q3	$2.15M	Sell
2016 Q2	$2.54M	Buy